Outcome of young children with high‐grade glioma treated with irradiation‐avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials
Pediatric Blood & Cancer2016Vol. 63(10), pp. 1806–1813
Citations Over TimeTop 10% of 2016 papers
Juan Espinoza, Kelley Haley, Neha Patel, Girish Dhall, Sharon L. Gardner, Jeffrey C. Allen, Joseph C. Torkildson, Albert Cornelius, Shahrad R. Rassekh, Antranik A. Bedros, Morris Etzl, James H. Garvin, Kamnesh R. Pradhan, Robin Corbett, Michael Sullivan, Geoffrey McGowage, Dagmar Stein, Rama Jasty, Stephen A. Sands, Lingyun Ji, Richard Sposto, Jonathan L. Finlay
Abstract
Irradiation-avoiding treatment strategies should be evaluated further in young children with HGG given similar survival rates to older children receiving standard irradiation-containing therapies.
Related Papers
- → MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma(2008)54 cited
- → MIB-1 labeling index in nonpilocytic astrocytoma of childhood(1998)28 cited
- → Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma(2007)13 cited
- Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.(2004)
- Experiencia en el tratamiento de gliomas de alto grado con temozolomida(2005)